Back to Results
First PageMeta Content
Cancer research / David H. Koch Institute for Integrative Cancer Research / David H. Koch / Tyler Jacks / Biomedical scientist / Medicine / Health / Massachusetts Institute of Technology


Mazumdar-Shaw Fellowship Description[removed]
Add to Reading List

Document Date: 2013-04-30 17:30:52


Open Document

File Size: 74,51 KB

Share Result on Facebook

City

Cambridge / Nanotechnology / Boston / /

Company

LinkedIn / MIT Postdoctoral Facebook / /

Country

India / /

Currency

USD / /

/

Facility

KI laboratory / National Institute of Medicine / David H. Koch Institute / MIT campus / Koch Institute / /

IndustryTerm

physical and chemical sciences / biopharmaceutical firms / mobile technology / health insurance / technology facility / cancer therapeutics / /

MedicalCondition

Indian cancer / cancer / disease / important cancer / metastasis / human cancer / boldest cancer / difficult cancer / total interdisciplinary cancer / /

MedicalTreatment

cancer therapeutics / /

Organization

National Academy of Science / MIT Careers Office / American Association of Cancer Research / National Institute of Medicine / MIT / Harvard / Koch Institute Executive Committee / FDA / Mazumdar-Shaw International Oncology Fellowship Screening Committee / Postdoctoral Advisory Council / MIT’s David H. Koch Institute for Integrative Cancer Research / Koch Institute for Integrative Cancer Research / Koch Institute / MIT International Scholars Office / Center for Cancer Research / /

Person

Dana Farber Harvard / Salvador E. Luria / /

Position

biomedical research scientist / physicist / Professor / Executive Director / President / Howard Hughes Medical Investigator / and a member / researcher / faculty advisor / biologist / Professor of Biology Tyler Jacks / engineer / /

Product

Herceptin / Gleevec / /

ProvinceOrState

Maryland / Massachusetts / /

PublishedMedium

Cancer Research / /

Technology

cancer detection / bioinformatics / biotechnology / human genome / /

SocialTag